The French breast cancer screening programme: Epidemiological and economic results of the first round of screening

European Journal of Public Health

Volumn 6, Issue 1, 1996, Pages 43-48

  Wait, Suzanne H ^a,d   Allemand, Hubert M ^b,c  

^a CREDES   (France)

^b Caisse Nationale d'Assurance Maladie des Travailleurs Salaries   (France)

^c UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^d NONE   (France)

Author keywords

Breast cancer; Cost; Mammography; Screening programme

Indexed keywords

EID: 0001933773     PISSN: 11011262     EISSN: None     Source Type: Journal    
DOI: 10.1093/eurpub/6.1.43     Document Type: Article

References (29)

1. Wald NJ, Chamberlain J, Hackshaw A. Report of the European society for mastology breast cancer screening evaluation committee. The Breast 1993;2:209-16.
2. Rutqvist LE, Miller AB, Andersson I, et al. Reduced breast cancer mortality with mammography screening: an assessment of currently available data. Int J Cancer 1990;Suppl5:76-84.
3. Nystrom L, Rutqvist IE, Wall C, et al. Breast cancer screening with mammography: overview of Swedish randomized trials. Lancet 1993;341:973-8.
4. Allemand H. Le dépistage du cancer du sein: synthèse des expériences pilotes réalisées dans le cadre du Fonds National de Prévention, d'Education et d'Information Sanitaires (Breast cancer screening: presentation of the pilot projects run within the framework of the Fonds National de Prévention, d'Education et d'Information Sanitaires). Paris: CNAMTS, 1993.
5. Europe Against Cancer. European guidelines for quality assurance in mammography screening. Brussels: Council of the European Communities, 1992.
6. Forrest P. Breast cancer screening: report to the health ministers of England, Wales, Scotland and Northern Ireland by a working group chaired by professor Sir Patrick Forrest. London: Her Majesty's Stationery Office, 1987.
7. Lancry PJ, Wait S. Evaluation économique des dépistages de masse du cancer du sein: épropos de cinq programmes expérimentaux français. (Economic analysis of breast cancer screening: an analysis of 5 French pilot projects). Paris: CREDES Report No 997, 1993.
8. Elixhauser A. Costs of breast cancer and the cost-effectiveness of breast cancer screening. Int J Tech Assess Hlth Care 1991;7:604-15.
9. Montaville B, Lefaure C. Le dépistage du cancer du sein en France: programmes et projets (Breast cancer screening in France: programmes and projects). Paris: INSERM U.240, 1988.
10. Brown ML, Kessler LG, Rueter FG. Is the supply of mammographic machines outstripping need and demand? Ann Int Med 1990;113:547-52.
11. Fagnani F, Le Galès C, Lefaure C. Analyse économique du dépistage du cance du sein par mammographie: comparaison des différentes organisations (Economic analysis of breast cancer screening by mammography: a comparison of different organizational models). J d'Econ Méd 1989;7(5):319-31.
12. Eddy DM, Hasselblad V, McGivney W, Hendee W. The value of mammography screening in women under age 50 years. JAMA 1988;259:1512-9.
13. Kerlikowske K, Grady D, Barclay J, Sickles J, Eaton A, Ernster V. Positive predictive value of screening mammography by age and family history of breast cancer. JAMA 1993;270:2444-50.
14. Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Cancer Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years. 2. Breast cancer detection and death rates among women ages 50 to 59 years. Can Med Assoc J 1992;147:1459-88.
15. van der Maas PJ, de Koning HJ, van Inevel BM, et al. The cost-effectiveness of breast-cancer screening. Int J Cancer 1989;43:1055-90.
16. Moatti JP, Beja V, Eisinger F, Obadia Y, Alias F, Dressen C. Dépistage des cancers. In: Baudier F, Dressen C, Alias F, editors. Baromètre Santé 92: résultats de l'enquête annuelle sur la santé des Français (Health Survey 1992: results of the annual survey on the health status of French inhabitants). Paris: CFES, 1994:60-77.
17. Chamberlain J, Moss SM, Kirkpatrick AE, Michell M, Johns L. National Health Service breast screening programme results for 1991-2. BMJ 1993;7:353-6.
18. Verbeek ALM, Hendricks J, Holland R, et al. Mammographic screening and breast cancer mortality: age-specific effects in Nijmegen project, 1975-82. Lancet 1985;i:865-6.
19. Andersson I, Aspegren K, Janzon L, et al. Effect of mammographic screening on breast cancer mortality in an urban population in Sweden: results from the randomized Malmö Mammographic Screening Trial (MMST). BMJ 1988;297:943-8.
20. Tabar L, Fagerberg CJG, Gad A, et al. Recent results from the Swedish two-county trial of mammographic screening for breast cancer. J Epidemiol Commun Hlth 1989;43:107-14.
21. Frisell J, Eklund G, Hellström L, Librink E, Rutqvist L-E, Somell A. Randomized mammographic screening for breast cancer in Stockholm: design, first round results and comparisons. Breast Cancer Res Treat 1986;8:45-56.
22. Maccia C, Renaud R, Castellano S, et al. Quality control in mammography: an initiative in France. Br J Radiol 1994;67:371-84.
23. UK Trial of Early Detection of Breast Cancer Group: first results on mortality reduction in the UK trial of early detection of breast cancer. Lancet 1988;ii:411-6.
24. Habbema JDF, Lubbe JThN, van Oortmarssen GJ, et al. A simulation approach to cost-effectiveness and cost-benefit calculations of screening for early detection of disease. Eur J Oper Res 1987;29:159-66.
25. Clarke PR, Fraser NM. Economic analysis of screening for breast cancer: final report. Edinburgh: Final Report to the Home and Health Department, 1991.
26. Eddy DM. Screening for breast cancer. Ann Int Med 1989;111:389-99.
27. Okubo I, Glick H, Frumkin H, Eisenberg JM. Cost-effectiveness analysis of mass screening for breast cancer in Japan. Cancer 1991;67:2021-9.
28. de Koning HJ, van Ineveld BM, van Ortmarssen GJ, et al. Breast cancer screening and cost-effectiveness: policy alternatives, quality of life considerations and the possible impact of uncertain factors. Int J Cancer 1991;49:531-7.
29. Brown ML, Fintor L. Cost-effectiveness of breast cancer screening: preliminary results of a systematic review of the literature. Breast Cancer Res Treat 1993;25:113-8.